GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Market Cap

Gaush Meditech (HKSE:02407) Market Cap : HK$1,508 Mil (As of Dec. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gaush Meditech's share price for the quarter that ended in Jun. 2024 was HK$11.8. Gaush Meditech's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 148 Mil. Therefore, Gaush Meditech's market cap for the quarter that ended in Jun. 2024 was HK$1,746 Mil.

Gaush Meditech's quarterly market cap declined from Jun. 2023 (HK$7,095 Mil) to Dec. 2023 (HK$5,593 Mil) and declined from Dec. 2023 (HK$5,593 Mil) to Jun. 2024 (HK$1,746 Mil).

Gaush Meditech's annual market cap increased from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$7,626 Mil) but then declined from Dec. 2022 (HK$7,626 Mil) to Dec. 2023 (HK$5,593 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gaush Meditech's Enterprise Value for Today is HK$1,424 Mil.


Gaush Meditech Market Cap Historical Data

The historical data trend for Gaush Meditech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Market Cap Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 7,626.05 5,593.27

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only - 7,626.05 7,095.16 5,593.27 1,746.05

Competitive Comparison of Gaush Meditech's Market Cap

For the Medical Devices subindustry, Gaush Meditech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Market Cap distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Market Cap falls into.



Gaush Meditech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Gaush Meditech's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=HK$37.8*147.97
=HK$5,593

Gaush Meditech's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=HK$11.8*147.97
=HK$1,746

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gaush Meditech  (HKSE:02407) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Gaush Meditech Market Cap Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech Business Description

Traded in Other Exchanges
N/A
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Gao Tieta 2201 Interest of corporation controlled by you
Gaush Holding Ltd 2101 Beneficial owner
Cuprite Gem Investments Ltd 2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd. 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p. 2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p. 2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p. 2201 Interest of corporation controlled by you

Gaush Meditech Headlines

No Headlines